Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Yes, long term use of pantoprazole, a proton pump inhibitor, has been linked in studies to an increased risk of osteoporosis related fractures of the hip, wrist, and spine, as well as kidney problems such as acute interstitial nephritis and chronic kidney disease. Risk appears highest with high doses, use beyond one year, and in adults over 50 or those with other risk factors, though the absolute increase for most people remains small and the medication is often still necessary. Other considerations include low magnesium, vitamin B12 deficiency, and rebound acid symptoms if the drug is stopped abruptly, so several factors matter here and the details below explain what to watch for and when to talk with your doctor. Because bone pain, swelling, fatigue, muscle cramps, and changes in urination can point to either a medication side effect or a separate condition, it helps to sort your symptoms before your next appointment. Take a free, instant, online symptom check to better understand what may be driving how you feel and what steps to take next.
Last reviewed for medical accuracy: 09/13/2026
Pantoprazole is a proton pump inhibitor (PPI) commonly prescribed for gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related conditions. While PPIs like pantoprazole are generally safe and effective, long-term use has been linked to certain risks, notably bone fractures and kidney damage. Below, we’ll explore what the research tells us, what factors may increase your risk, and steps you can take to stay informed and protected.
Pantoprazole reduces the production of stomach acid by blocking the proton pumps in your stomach lining. It’s often prescribed when other antacids or H2 blockers aren’t enough to relieve symptoms such as heartburn, acid regurgitation, or ulcers.
Common pantoprazole side effects include:
These tend to be mild and resolve on their own. However, concerns grow when pantoprazole is used continuously for months or years.
In 2010, the U.S. Food and Drug Administration (FDA) issued a safety communication noting that long-term PPI use (one year or longer) can be associated with an increased risk of fractures of the hip, wrist, and spine. Subsequent studies have generally supported a modest increase in fracture risk, especially in people who have other osteoporosis risk factors.
Key points from the evidence:
Several mechanisms may explain how pantoprazole side effects include impacts on bone health:
If you need to stay on pantoprazole:
One of the more serious pantoprazole side effects is acute interstitial nephritis, an inflammation of the kidney’s filtering units. Although rare, it can occur at any time—even after months of uneventful therapy.
Signs and symptoms may include:
If AIN is suspected, stopping the PPI usually leads to recovery, though steroids are sometimes needed.
In 2016, a large observational study published in JAMA Internal Medicine linked long-term PPI use to a 20–50% higher risk of chronic kidney disease compared to non-users. A follow-up study found similar risks for progression to end-stage renal disease.
Possible mechanisms:
To protect your kidneys:
For many people with persistent acid reflux or peptic ulcers, the benefits of pantoprazole—such as reducing ulcer complications and improving quality of life—outweigh the potential risks. However, being proactive about potential side effects is wise:
If you experience any of the following, contact your healthcare provider promptly:
For non-urgent concerns, you might also try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Always speak to a doctor about anything that could be life threatening or serious. Your healthcare provider can help you weigh the pros and cons of pantoprazole therapy and suggest the best plan for your individual needs.
(References)
* Lespessailles E, Toumi H. Proton Pump Inhibitors and Bone Health: An Update Narrative Review. Int J Mol Sci. 2022 Sep 14;23(18). doi: 10.3390/ijms231810733. Epub 2022 Sep 14. PMID: 36142643; PMCID: PMC9504265.
* Vaezi MF, Yang YX, Howden CW. Complications of Proton Pump Inhibitor Therapy. Gastroenterology. 2017 Jul;153(1):35-48. doi: 10.1053/j.gastro.2017.04.047. Epub 2017 May 19. PMID: 28528705.
* Chinzon D, Domingues G, Tosetto N, Perrotti M. SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS. Arq Gastroenterol. 2022 Apr-Jun;59(2):219-225. doi: 10.1590/S0004-2803.202202000-40. PMID: 35830032.
* Thurber KM, Otto AO, Stricker SL. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use. Am J Health Syst Pharm. 2023 Apr 8;80(8):487-494. doi: 10.1093/ajhp/zxad009. PMID: 36629265.
* Freedberg DE, Kim LS, Yang YX. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017 Mar;152(4):706-715. doi: 10.1053/j.gastro.2017.01.031. PMID: 28257716.
* Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193. PMID: 26752337; PMCID: PMC4772730.
* Xia B, He Q, Smith FG, Gkoutos VG, Nirantharakumar K, Kuo ZC, Wang D, Feng Q, Cheung EC, Dai L, Huang J, Yu Y, Meng W, Qin X, Yuan J. Individualized prevention of proton pump inhibitor related adverse events by risk stratification. Nat Commun. 2024 Apr 27;15(1):3591. doi: 10.1038/s41467-024-48007-8. Epub 2024 Apr 27. PMID: 38678022; PMCID: PMC11055952.
* Yamawaki C, Nakagawa S, Ikuta K, Katsube Y, Imayoshi N, Shigetsura Y, Hira D, Yamamoto S, Matsubara T, Yanagita M, Terada T. Association between Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Acute Kidney Injury: A Nested Case-Control Study. Kidney360. 2024 Sep 1;5(9):1262-1269. doi: 10.34067/KID.0000000000000528. Epub 2024 Aug 1. PMID: 39088266; PMCID: PMC11441815.
* Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Curr Gastroenterol Rep. 2010 Dec;12(6):448-57. doi: 10.1007/s11894-010-0141-0. PMID: 20882439; PMCID: PMC2974811.
* Zhang M, Liu W, Liu Y, Cheng Q, Zhang X, Qian N, Qi J, Chen T, Yu Y. Proton pump inhibitor increases intestinal epithelial paracellular permeability via the p38-MAPK/NF-κB signaling pathway. Mol Biol Rep. 2025 Dec 10;53(1):170. doi: 10.1007/s11033-025-11336-y. Epub 2025 Dec 10. PMID: 41369838; PMCID: PMC12696144.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.